AMAG Pharmaceuticals to Host Conference Call on February 17, 2016 at 8:00 a.m. ET to Discuss Financial Results for the Fourt...
February 04 2016 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will
report unaudited consolidated financial results for the fourth
quarter and year ended December 31, 2015 before the U.S. financial
markets open on Wednesday, February 17, 2016. The announcement will
be followed by a conference call and webcast with slides at 8:00
a.m. ET, during which management will present an update on recent
developments and discuss the company’s fourth quarter and full year
2015 financial and operating results.
To access the conference call via telephone, please dial (877)
412-6083 from the United States or (702) 495-1202 for international
access. A telephone replay will be available from approximately
11:00 a.m. ET on February 17, 2016 through midnight on February 24,
2016. To access a replay of the conference call, dial (855)
859-2056 from the United States or (404) 537-3406 for international
access. The pass code for the live call and the replay is
44838187.
The call will be webcast with slides and accessible through the
Investors section of the company’s website at www.amagpharma.com.
The webcast replay will be available from approximately 11:00 a.m.
ET on February 17, 2016 through midnight on March 18, 2016.
About AMAGAMAG Pharmaceuticals uses its
business and clinical expertise to develop and commercialize
products that provide clear benefits and improve people’s lives.
Based in Waltham, MA, AMAG has a diverse portfolio of products in
the areas of maternal health, anemia management and cancer
supportive care. AMAG continues to work to expand the impact of
these and future products for patients by delivering on its growth
strategy, which includes organic growth, as well as the pursuit of
products and companies that align with AMAG’s existing therapeutic
areas or those that could benefit from its proven core
competencies. For additional company information, please visit
www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contact:
Maryann Cimino
Manager, Corporate Communications & External Affairs
617-498-3375
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Sep 2023 to Sep 2024